Advanced therapeutics, including cell and gene therapies, require specialized knowledge and the ability to navigate a complex, continuously evolving landscape. Therefore, it's essential to partner with a CDMO with the experience, capacity, network, and ability to adapt and personalize its approach. With our extensive expertise, end-to-end services, and robust global supply network, we can effectively help biotechnology and pharmaceutical companies navigate the journey from molecule to medicine. Our specific capabilities for advanced therapies include translational research services, clinical supply chain solutions, and the development and manufacturing of viral vectors, cell therapy, and mRNA.
